Live Breaking News & Updates on Bone Oncology

Stay updated with breaking news from Bone oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Chandrajit P. Raut Appointed Dana-Farber's Surgeon-in-Chief

Chandrajit P. Raut Appointed Dana-Farber's Surgeon-in-Chief
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United States , Dana Farber Cancer Institute , Chandrajit Raut , Laurieh Glimcher , Chandrajitp Raut , Stanford University , Md Anderson Cancer Center , Harvard Medical School , University Of Oxford , Department Of Surgery , National Institutes Of Health , Division Of Surgical Oncology , Dana Farber Cancer , Surgical Oncology , Distinguished Chair , Cancer Care , Surgery Director , Bone Oncology , Harvard Medical , Massachusetts General Hospital , National Institutes , Co Principal Investigator , Principal Investigator , Mass General , Surgical Oncology Insights , Clinical Trials ,

Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST) at ASCO Annual Meeting - Cogent Biosciences (NASDAQ:COGT)

Bezuclastinib + sunitinib combination therapy reached median progression free survival (mPFS) of 19.4-months and 33% ORR in subset of advanced GIST patients with one prior treatment Encouraging long-term safety and ....

United States , Andrew Robbins , Andrew Wagner , Christi Waarich , Alliance For Research , Cogent Biosciences Inc , Cogent Research Team , Life Raft Group , American Society Of Clinical Oncology , Harvard Medical School , Bezuclastinib Clinical Development , Dana Farber Cancer Institute , Dana Farber Cancer , Gastrointestinal Stromal Tumors , American Society , Clinical Oncology , Annual Meeting , Chief Executive Officer , Senior Physician , Bone Oncology , Associate Professor , Harvard Medical , Poster Session , Jefferies Global Healthcare Conference , Cogent Biosciences , Private Securities Litigation Reform Act ,

Bringing CAR-T into the community: 'Healthcare is like politics – it's local'

Today, just two in ten patients have access to CAR-T therapy in the US. Considering this challenging landscape, the shift has focused from academic centers to community clinics, as they may be able to serve more patients. ....

United States , Jeff Patton , Cindy Perettie , Tennessee Oncology , Bone Oncology , Markets Amp Regulations , Biopharma Culture , Emerging Markets , Cell Amp Gene Therapies , Ar T , Cell And Gene Therapy , Cell Therapy ,

Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma

Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Palo Alto , Ian Flinn , Gabriela Jairala , Ahmed Hamdy , Joyce Lonergan , Vincerx Pharma Inc , Securities Exchange , Exchange Commission , National Institutes Of Health , Lifesci Advisors , Pharma Announces Compelling Clinical Efficacy , National Institutes , Chief Executive Officer , Vincerx Scientific Advisory Board , Chief Scientific Officer , Bone Oncology , Versaptx Platform , Vincerx Pharma , Securities Act , Securities Exchange Act , Sci Advisors ,

Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma

Investigators from the National Institutes of Health report 2 partial responses in 3 peripheral T-cell lymphoma patients and 1 PR in 2 double-hit diffuse large b-cell lymphoma patients in ongoing. ....

Palo Alto , United States , Joyce Lonergan , Ahmed Hamdy , Ian Flinn , Gabriela Jairala , Lifesci Advisors , Exchange Commission , National Institutes Of Health , Globenewswire Inc , Securities Exchange , Vincerx Pharma Inc , Chief Executive Officer , Scientific Advisory Board , Chief Scientific Officer , Bone Oncology , Versaptx Platform , Securities Act , Securities Exchange Act , Sci Advisors ,